But compressing timetables is also pushing the limits of drug manufacturing capabilities. This is particularly true for biologic agents ... with a production workflow based on modular pods ...

and energy requirements by 50% One of the underappreciated challenges of the biologics manufacturing workflow is the fill-finish step. This describes the last mile of production, when the drug is ...

In this GEN webinar, experts from Sanofi, Evotec Biologics, and Sartorius will share insights and strategies from their ...